Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients

BACKGROUND: Maximal safe resection followed by adjuvant chemoradiotherapy (CRT) with temozolomide (TMZ) is the standard treatment for newly diagnosed glioblastoma multiforme (GBM) patients. Time of initiation of postoperative adjuvant therapy has been demonstrated to impact on prognosis. For GBM pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Maochen, Xu, Fei, Ni, Weiqiong, Qi, Weixiang, Cao, Weiguo, Xu, Cheng, Chen, Jiayi, Gao, Yunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797492/
https://www.ncbi.nlm.nih.gov/pubmed/35117910
http://dx.doi.org/10.21037/tcr-20-1718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797492/
https://www.ncbi.nlm.nih.gov/pubmed/35117910
http://dx.doi.org/10.21037/tcr-20-1718

Ejemplares similares